Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

ViiV

- PMLiVE

Janssen and Gilead extend HIV collaboration

Will develop single tablet regimen that combines Prezista, Tybost, emtricitabine and tenofovir alafenamide

- PMLiVE

GSK squares up to Merck with shingles vaccine data

Trial shows vaccine cut the risk of shingles in over 50s by 97%

- PMLiVE

GSK holds on to older products

No suitable buyer found for portfolio of established medicines

- PMLiVE

US R&D hit in GSK’s latest cost-cutting round

CRO Parexel rumoured to contract “up to 450” GSK employees

- PMLiVE

US R&D hit in GSK’s latest cost-cutting round

CRO Parexel rumoured to contract “up to 450” GSK employees

- PMLiVE

GSK names drug hunter challenge winners

Competition finds promising projects in anti-infectives, cancer and neurodegenerative diseases

- PMLiVE

GSK’s oncology president joins NuCana board

Paolo Paoletti also has experience in cancer research at Lilly

- PMLiVE

AIDS pandemic now at ‘the beginning of the end’

ONE Campaign says drug access is making the difference, but there's still more to do

- PMLiVE

First trial results positive for GSK Ebola vaccine

ChAd3-EBO is safe and able to stimulate response

- PMLiVE

GSK tops pharma access to medicines table

But corruption and intellectual property issues in developing nations

- PMLiVE

GSK first to file IL-5 antagonist for asthma

Mepolizumab submitted as a treatment for severe eosinophilic asthma

- PMLiVE

NICE backs GSK drug for leukaemia

Arzerra on course for NHS use in blood cancer

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links